T 0305/07 (Trisulfides/PFIZER) of 20.5.2011

European Case Law Identifier: ECLI:EP:BA:2011:T030507.20110520
Date of decision: 20 May 2011
Case number: T 0305/07
Application number: 99933442.8
IPC class: C07K 1/113
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 81 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Method for the production of recombinant peptides with a low amount of trisulfides
Applicant name: Pfizer Health AB
Opponent name: Novo Nordisk A/S
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 83
European Patent Convention Art 123(2)
European Patent Convention Art 123(3)
European Patent Convention Art 114(2)
Rules of procedure of the Boards of Appeal Art 12(4)
Rules of procedure of the Boards of Appeal Art 122 half Sent
Keywords: Admissibility of experimental evidence (no); main request, auxiliary requests 1 and 2 - added subject-matter (yes);
auxiliary request 3 - added subject-matter, extension of scope (no); sufficiency of disclosure, novelty, inventive step (yes)
Catchwords:

-

Cited decisions:
G 0002/88
T 0939/92
T 0411/02
T 0936/02
T 0190/04
T 1335/05
Citing decisions:
T 0005/14

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t070305eu1.html

Date retrieved: 17 May 2021

11 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: V Priority

Case Law of the Enlarged Board

General Case Law